MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 74 filers reported holding MIRUM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $41,938,323 | +7.7% | 1,621,118 | 0.0% | 46.52% | +3.3% |
| Q1 2023 | $38,939,254 | +23.2% | 1,621,118 | 0.0% | 45.05% | +22.2% |
| Q4 2022 | $31,611,801 | -21.7% | 1,621,118 | -15.6% | 36.87% | -21.3% |
| Q3 2022 | $40,363,000 | +8.0% | 1,921,118 | 0.0% | 46.86% | -14.7% |
| Q2 2022 | $37,385,000 | -11.6% | 1,921,118 | 0.0% | 54.94% | +26.5% |
| Q1 2022 | $42,303,000 | +38.1% | 1,921,118 | 0.0% | 43.42% | +98.6% |
| Q4 2021 | $30,642,000 | -19.9% | 1,921,118 | 0.0% | 21.86% | +240.2% |
| Q3 2021 | $38,269,000 | +15.2% | 1,921,118 | 0.0% | 6.42% | -1.0% |
| Q2 2021 | $33,216,000 | -12.8% | 1,921,118 | 0.0% | 6.49% | +10.7% |
| Q1 2021 | $38,077,000 | +13.5% | 1,921,118 | 0.0% | 5.86% | +59.1% |
| Q4 2020 | $33,543,000 | – | 1,921,118 | – | 3.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |